Together we will beat cancer

Donate

Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities need urgent support’

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

Read More

Coronavirus and cancer – latest updates

We’re pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer.

Read More

ASCO 2019 news: targeted treatment takeover, drugging the ‘undruggable’, obesity and blood tests

The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.

Read More

International Women’s Day: a Wikipedia edit-a-thon for women in cancer research 

Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.

Read More

Science Surgery: ‘What’s being done to use treatments in different types of cancer?’

This entry is part 7 of 22 in the series Science Surgery

In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.

Read More

How can CRISPR genome editing shape the future of cancer research?

CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.

Read More

Scientists are combining drugs and radiotherapy, hunting for better results

This entry is part 7 of 11 in the series Radiotherapy

By combining radiotherapy with different kinds of drugs, scientists hope that both can be made more effective.

Read More

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

Read More

Reviewing our year

Read about some of the progress we’ve made over the last financial year and about some of the big themes from the year.

Read More

PARG inhibitors: tipping the scales with a new experimental drug

Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer’s balance.

Read More